FDMT
4D Molecular Therapeutics Inc
NASDAQ: FDMT · HEALTHCARE · BIOTECHNOLOGY
$8.87
+0.68% today
Updated 2026-04-30
Market cap
$479.88M
P/E ratio
—
P/S ratio
5.63x
EPS (TTM)
$-2.42
Dividend yield
—
52W range
$3 – $12
Volume
0.8M
4D Molecular Therapeutics Inc (FDMT) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |